Comparing Menghini-type Needle and Franseen-type Needle in EBUS-TBNA for Sarcoidosis
Recruiting
N/A
Interventional Study
Suspected Sarcoidosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 128 (estimated)
- Sponsor
- University Health Network, Toronto · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This randomized pilot clinical trial aims to examine whether sample collection with Franseen-type needles are effective for the diagnosis of sarcoidosis, as defined by improved sample quality for pathological diagnosis compared to the conventional Menghini-type needle.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* -Any adult patient aged 18 years or older with enlarged mediastinal and/or hilar lymph nodes
* (≥10 mm short-axis diameter on a CT scan), suspected as having sarcoidosis based on clinical
* history, physical exam, and other investigations, and booked for EBUS-TBNA.
Exclusion …
Contacts